SB667

  • insuling signing 012420 ftr

  • insulinpens 102919

     

  • insulin 053019SPRINGFIELD – State Senator Julie Morrison (D-Deerfield) voted in support of a measure that will cap patients’ out-of-pocket costs for prescription insulin at $100 for a 30-day supply.

    “No one should have to choose between getting the medication they need to survive and putting food on their family’s table,” Senator Morrison said. “I applaud the efforts of my colleagues to pass this life-saving measure.” 

    Senate Bill 667 caps co-payments for insulin at $100 per month for all patients, regardless of the supply they require. The cap, however, only applies to commercial insurance plans regulated by the state.

    About 1.3 million adults in Illinois have diabetes – 12.5% of the state’s population – according to the Illinois Department of Public Health. On average, people with diabetes pay $475 a month on insulin, the Health Care Cost Institute reports. The high cost drives many patients to ration their insulin supply, which can result in blindness, kidney failure or death.

    “Insulin is not an option for more than one million Illinois residents,” Morrison said. “It is time Illinois leads by example to hold pharmaceutical companies accountable for choosing to maximize profits at the expense of consumers’ health.”  

    If the bill becomes law, Illinois will become the second state in the country to cap out-of-pocket prices.

    The legislation now heads to Gov. JB Pritzker, who previously pledged his support of the measure.

  • stadelman 101119SPRINGFIELD - Amid life-threatening increases in the cost of prescription insulin, Steve Stadelman, a State Senator and father to a diabetic son, voted with fellow lawmakers today to cap insulin copayments. The legislation will cap patients’ out-of-pocket costs for prescription insulin at $100 for a 30-day supply.

    “I have seen the struggle that diabetics face every day,” said Stadelman, a Rockford democrat. “Diabetes is a lifelong affliction for those who have it. It shouldn’t also be the cause of financial stress for their families.”

    There are currently over 30 million Americans who have diabetes, according to the American Diabetes Association. An individual with Type 1 diabetes, a lifelong condition that often begins at birth, will spend an average of $5,705 per year on insulin alone.

    “Without adequate insurance, many people with diabetes can’t afford the insulin they need to survive,” Stadelman said. “Rationing insulin leads to further health problems and more expensive health care costs in the long term. This legislation will provide medical and financial relief for thousands in the Rockford area and across the state of Illinois.”

    The price of insulin has tripled between 2002 and 2013, which has led to many patients rationing their insulin and sacrificing other daily needs to pay for the medication.

    Senate Bill 667 passed with a vote of 48-7 and would make Illinois the second state in the nation to cap prescription insulin co-payments.

  • insulinpens 102919

  • manar 102819SPRINGFIELD – An initiative to reign in the soaring cost of insulin for diabetes patients moved forward today.

    Senate Bill 667, sponsored by State Senator Andy Manar (D-Bunker Hill), would cap co-payments for insulin at $100 per month for all patients regardless of the supply they require. The cap would only apply to commercial insurance plans regulated by the state. The legislation was approved 15-3-1 by the Senate Insurance Committee.

    “For over a million Illinois residents, insulin is an absolute necessity. Without it, they will die,” Manar said. “Pharmaceutical companies are leveraging that fact in order to maximize profits. It’s time we hold them accountable.”

  • insulin 053019CHAMPAIGN – To make insulin more affordable for citizens in Champaign and Vermilion counties, State Senator Scott Bennett moved to cap patients’ out-of-pocket costs at $100 for a 30-day supply.

    As lawmakers prepare to return to Springfield next week for the fall veto session, insulin will be a major topic of interest. Bennett is a co-sponsor of legislation that would make Illinois the second state to cap insulin copayments. 

    “The price of insulin has tripled over the span of a decade and diabetics are resorting to desperate measures due to the price spike,” Bennett said. “You can’t just cut back on insulin. Patients deserve affordable access to this life-saving prescription drug, and they can’t wait.”

    The American Diabetes Association reports there are more than 30 million Americans who have diabetes, with 1.25 million having Type 1 diabetes. The condition requires daily administration of insulin to survive.

    This legislation, Senate Bill 667, also directs Attorney General Kwame Raoul’s office to investigate reasons for rising prescription insulin costs and to ensure consumer protections in their pricing. The attorney general’s office will issue a one-time report detailing its findings and make public policy recommendations for controlling and preventing overpricing of prescription insulin.

    “Nobody should be forced to decide between paying for food or their medication,” Bennett said. “I will continue to work with the lead sponsor of Senate Bill 667, State Senator Andy Manar (D-Bunker Hill) to ensure this becomes law.”

  • stadelman 101119CHICAGO – Amid life-threatening increases in the cost of prescription insulin, Steve Stadelman, a state Senator and father to a diabetic son, joined other lawmakers at a press conference this morning to urge the passage of a measure that would cap the medicine’s cost at $100 per 30-day supply.

    “My teenage son is diabetic, and as a parent, I have seen the struggle that diabetics face every day,” said Stadelman (D-Rockford). “Diabetes is a lifelong affliction for those who have it. It should not also be the cause of financial stress for their families.”

    There are currently over 30 million Americans who have diabetes, according to the American Diabetes Association. An individual with Type 1 diabetes, a lifelong condition that often manifests at birth, will spend on average $5,705 per year on insulin alone.

    “Many people do not have adequate insurance, and because of that, they cannot afford the insulin they need to survive,” Stadelman said. “Rationing insulin leads to further health problems and more expensive health care costs in the long run.”

    If passed, Senate Bill 667 would make Illinois the second state to cap prescription insulin co-payments.

    The bill is expected to be heard in the upcoming legislative session that begins Oct. 28.

  • koehler 091719SPRINGFIELD – State Senator Dave Koehler joined with colleagues for a press conference today highlighting a solution to counter the skyrocketing cost of prescription insulin.

    “For far too long pharmaceutical companies have been allowed to take advantage of people who require this medication to live, and it’s unacceptable,” Koehler (D-Peoria) said. “Working to ease the financial burden on families who require prescription insulin is the humane thing to do.”

    Senate Bill 667 would cap out of pocket insulin expenses at $100 for a 30-day supply.

    According to the American Diabetes Association, there are over 30 million Americans who have diabetes, with 7.4 million of them who require prescription insulin to survive. The increasing cost of the medication has forced many of these patients to choose between purchasing vital medication and other financial obligations.

    “There shouldn’t be a choice to make in the first place,” Koehler said. “Those who suffer from diabetes should be able to acquire the necessary prescription medication without it breaking the bank.”

  • insulin 072219SPRINGFIELD – State Senator Rachelle Crowe is working to make insulin more affordable for Metro East residents.

    Crowe (D-Glen Carbon) is a chief cosponsor of Senate Bill 667, which caps the out-of-pocket costs for patients to $100 for a 30-day supply of prescription insulin.

    “People who require insulin do not have a choice in their medication,” Crowe said. “Drug manufacturers should not be able to raise the cost to line their own pockets at a patient’s expense.”

    For people with severe diabetes, insulin could mean the difference between life and death, but regular price hikes make insulin difficult to afford for the uninsured and those whose coverage requires significant cost sharing.

    Senate Bill 667 also directs the Attorney General's office to investigate reasons for rising prescription insulin costs to ensure sufficient consumer protections. The Attorney General's office will issue a one-time report detailing its findings and make public policy recommendations for controlling and preventing overpricing of prescription insulin.

    The lead sponsor of Senate Bill 667 is State Senator Andy Manar (D-Bunker Hill).

  • insulin 053019SPRINGFIELD – State Senator Andy Manar has introduced legislation that would protect Illinoisans from the skyrocketing price of insulin by capping the amount patients would need to pay for the life-saving medication.

    “In the last 20 years or so we’ve seen the price of insulin rise to outlandish levels,” said Manar, a Bunker Hill Democrat. “We have a responsibility as lawmakers to help get these prices under control and make this life-saving medication more available to those who need it.”

    Senate Bill 667 would cap co-payments for insulin at $100 per month for all patients regardless of the supply they require.

    The price of insulin has increased exponentially in the U.S. in the past several years. According to a 2016 study, the price of the drug tripled between 2002 and 2013. 

    If passed, the measure would make Illinois the second state in the country to cap insulin payments.

    Nearly 7.5 million Americans with diabetes rely on insulin to manage their blood sugar levels. Price increases have left many of them struggling to pay for the drug and at risk of deadly consequences. Some people are forced to ration the medication until they can afford the next prescription or forego it altogether.

    “This isn’t just a financial issue, these price increases are putting peoples’ lives at stake,” Manar said. “We need immediate action on this issue and that’s what this bill represents.”